GLP-1 demand is transforming how obesity care is delivered and paid for. Today, 40% of US adults have obesity and one in eight report having taken a GLP-1.^1,2 As patients turn to GLP-1s over bariatric surgery, obesity service line models must change. Health systems are adapting to the heightened demand while contending with tight margins, limited insurance coverage, and persistent access disparities.

At this recent innovation showcase, health system leaders and their partners shared how they are reimaging obesity services.

Here’s what we learned.